Big Buttons

• PCAC to discuss 503A bulks list substances

  FDA’s Pharmacy Compounding Advisory Committee has announced that it will hold two meetings (!) between now and year-end to consider recommending several bulk drug substances to the 503A Bulks List.  read more →

• Next APC regional meeting: Seattle

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Seattle area October 3. read more →

• Don’t skip EduCon’s final (fantastic) session(s)

  The final session of this year’s EduCon is coming up in just a few weeks, and it’s a special double helping of legal goodness. read more →

• Welcome, new PFMs!

  We’ve added 31 Pharmacy-Facility Members since February! read more →

• Let’s talk about that Lilly announcement

  There’s been plenty of coverage of Eli Lilly’s announcement this week that it will sell vials of Zepbound directly to consumers at a discount. But the company seems to have left out a few important caveats. read more →

• Our response to the op-ed in The Hill

  The Hill published an editorial by Dr. Kenneth McCall titled “Fake, unsafe weight-loss drugs are a worsening public health dilemma” in which he makes unfounded claims about pharmacy compounding. Here’s the response from our CEO. read more →

• The shortage ends … then what? (Find out at CCH) 

  We’ve added a new session to the Compounders on Capitol Hill lineup. Don’t miss the discussion of what’s on many a compounder’s (and regulators’ … and reporters’...) mind. read more →

• A new bronze corporate patron

  A big welcome to Ro, APC’s newest tier-level corporate patron! read more →

More News

Remember last year’s Tricare/ESI recoupment attempt – in which the agency tried to recoup funds on compounding claims from 2015 from about 400 compounding pharmacies, but then reversed course when challenged by APC and NCPA? And remember how Tricare indicated that funds it recouped would be returned to affected pharmacies who appealed the action?

Yeah, well, now it’s been six months, and for many of those pharmacies that filed the proper appeal paperwork, their funds have not yet been returned.

This week, NCPA’s Ronna Hauser, on behalf of NCPA and APC, reached out to Tricare leaders to express concern about ESI’s dithering in returning pharmacy funds as promised, and reminding the agency that in some cases, more than $100,000 was taken from individual pharmacies and is being held without due process. Came the reply that Tricare is looking into the situation and will get back to us.

So for now we wait. Some more.